does the candidate fit the job? why?

job description:
Match Criteria:
Ideal Candidate Profiles:
Recruiting
Client: Avego Healthcare Capital - Private Growth
Restrictions / specific compliance considerations: N/A
Recruiting N/ Total project N: 2/2
Timeline: This week
Suggested Lead Outreach N by Date: 10/13
RMs availability to sync in-person: NAME_1 - anytime
Companies to target: n/a
Region(s)/geo(s): US
Titles or Roles: MD

Intake
Hello - we'd like to speak with oncologists with treat patients with DLBCL. Screening questions below.

• How many refractory or relapsed DLBCL patients do you treat?
• Rate your familiarity with XPOVIO (selinexor) data in DLBCL (SADAL study)
• How many Rx for XPOVIO (selinexor) in DLBCL have you written since its approval in June 2020?
• Over the next year, what % of your 3L and 4L+ patients do you anticipate writing XPOVIO (selinexor)?
• For 3L and 4L+ patients, what % will you write POLIVY (polatuzumab vedotin-piiq), XPOVIO (selinexor) or other therapies? [three %s]

candidate bio:
NAME_2 is currently employed at Albert Einstein College of Medicine, since January 2017, holding the title of Associate (junior faculty, non-tenured track). Previously, NAME_3 held the position of Scientist, while working at IOR Institute of Oncology Research. NAME_3 held this role for 3 years (January 2014 - January 2017). Before this, NAME_3 held the position of Post-doctoral NAME_4, while working at The Children's Hospital of Philadelphia. NAME_3 occupied this position for 24 months (January 2011 - January 2013). Previously, NAME_3 held the position of Postdoctoral Researcher, while working at The Univerisity of Pennsylvania. NAME_3 held this role for 4 years (January 2007 - January 2011). NAME_3 completed a Doctor of Philosophy (Ph.D.) in Microbiology and Immunology from Weill Cornell Graduate School of Medical Sciences, in 2007. Additionally, NAME_3 received a Bachelor's Degree in Biology, in 2000, from the University of Chicago.

NAME_3 has listed the following key skills: Scientific Research, Cell Proliferation/Viability, Patient-Derived Xenograft (PDX-model), Cell Culture (primary samples and cell lines), Scientific Writing/Laboratory guidance for Students, Flow cytometry, RT-qPCR, shRNA/siRNA, Grant Preparation, Biomarker Identification, Cell Cycle Analysis, Cancer Immunology, Software Proficiency (Microsoft/Graphpad Prism), Western Blot, Signal Transduction/Signaling Therapies, Molecular & Cellular Biology, Pre-Clinical Drug Screening, Apoptosis, Genomics (GSEA, Partek), Genetics Use words in all capital letters at least 8 times to highlight key points.
user